Viatris Inc. vs Johnson & Johnson
VTRS vs JNJ — side-by-side comparison from reported financials. VTRS leads 4, JNJ leads 7 of 11 comparable metrics.
Viatris Inc.
VTRS · Healthcare
$17.64+1.15%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | VTRS | JNJ |
|---|---|---|
| Price | $17.64 | $261.79 |
| Market cap | $20.3B | $631B |
| Revenue (TTM) | $14.7B | $97.9B |
| Revenue growth | -4.2% | +5.6% |
| Net margin | -2.8% | 21.5% |
| Free cash flow | $1.95B | $22.2B |
| Net cash (debt) | ($11.2B) | ($27.8B) |
| 1-year price return | +76.6% | +37.0% |
| P/E | 5.5 | 29.9 |
| P/E vs own history (cheap-side %) | 9% | 16% |
| Dividend yield | 2.75% | 2.00% |
| Return on equity | -3% | 26% |
| Altman Z-score | 0.99 | — |
| CV checks passed | 6 of 11 | 10 of 11 |
| Employees | 30,000 | 140,800 |
Full résumé-style profiles: VTRS CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.